Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Cash Flow From Operating Activities

Download as xlsx, pdf, or txt
Download as xlsx, pdf, or txt
You are on page 1of 10

Consolidated Statement of Cash Flows

For the year ended 31 December 2014


RM
RM
Cash flow from operating activities
Profit before tax
Add/(less): non-cash items
Depreciation
Gain on disposal of PPE
GW impairment loss
Loss on disposal of PPE
Add/(less): Changes in working capital
Increase in Inventory
Increase in AR
Increase in AP
Increase in Accrued liabilities
Increase in Unearned revenues
Increase in Deferred tax
Net cash flow from operating activities
Cash flow from investing activities
Sales of PPE
Purchase of PPE
Long term loan
Net cash flow from investing activities
Cash flow from financing activities
Sales of bond
Repayment of long term loan
Redemption of preference shares
Issuance of share capital
Interest income
Interest received
Dividend income
Dividend paid
Net cash flow from financing activities
Net increase in cash & cash equivalent
Beginning cash balance
Ending cash balance

495,310

Consolidated Statement of Cash Flows


For the year ended 31 December 2014
RM
RM
Cash flow from operating activities
Profit before tax
495,310
Add/(less): non-cash items
Depreciation - PPE
46,000
Gain on disposal of sub.
(16,310)
Share of Associate profit
(38,000)
GW impairment - Parent
36,000
GW impairment - Associate
18,000
Increase in Doubtful debt
28,000
Add/(less): Changes in WC
Increase in Inventories
(71,000)
Increase in AR
(69,600)
Increase AP
25,000
Derease in Accrued interest
(5,000)
Net cash flow from operating activities
(46,910)
Cash flow from Investing activities
Purchase PPE
(83,000)
Inv in assoc - dividend received
11,100
Disposal of subsidiary (90.79-4.5)
86,290
Net cash flow from investing activities
14,390
Cash flow from financing activities
Dividend paid - NCI
(11,180)
Payment of l/t notes pble
(64,917)
Tax paid
(138,693)
Dividend paid - Parent
(74,000)
Net cash flow from financing activities
(288,790)
Net increase in cash and cash equivalents
174,000
Beginning cash balance (125+63-120.5)
67,500
Ending cash balance (180+197.5-136)
241,500

b/d
Increase

Inventory
96
71
167

AR
b/d
Increase

44
69.6
113.6

AP
SUB-disposal

13

c/d

30
43

Tax payable
Cash
c/d

138.693
7
145.693

Div payable
Cash
c/d

74
84
158

Prov for d/debt

Decrease
c/d

b/d
Cash

Accrued Interest Expense


5
15
20

PPE
899
83
982

b/d
SUB

Inv - Quoted shares


130
30
160

b/d
share of assoc profit

Inv - associates
124.5
38

162.5

b/d

Intangible assets
89.5

89.5

SUB-disposal (20% x 93.1)


Cash
c/d

SUB-disposal
cash
c/d

NCI
18.62
11.18
136
165.8

L/t notes payable


48.000
64.917
134.083
247.000

entory
SUB-disposal
c/d

36
131
167

AR
SUB-disposal
Doubtful debt
c/d

27.6
28
58
113.6

AP
b/d
Increase

payable
b/d
Tax expense

payable
b/d
SCI

18
25
43

8.500
137.193
145.693

74
84
158

or d/debt
Increase

28
28

terest Expense
b/d

20
20

PPE
SUB-disposal
c/d
Depreciation

86
850
46
982

oted shares

c/d

ssociates
Share of tax
Impairment
c/d
Dividend

160
160

11.4
18
122
11.1
151.4

ble assets
GW impairment
SUB-disposal
c/d

36
30
23.5
89.5

NCI
b/d
SCI

es payable
b/d

128
37.8
165.8

247

247

AR

You might also like